| Source publication date | (month of publication) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Wellness publication |
| Population | Men |
| Source | One Day MD (Aesthetics Advisor) |
| URL | onedaymd.aestheticsadvisor.com/2026/08/testosterone-mens-health-healthy-aging.html (opens in a new tab) |
Specific Claim Evaluated
Rising testosterone prescribing reported by Epic Research reflects a healthcare utilization trend and is not evidence that all men should be tested or treated; diagnosis requires symptoms and consistently low laboratory values.
Primary Research Supporting or Contradicting the Claim
Guidelines restrict diagnosis to men with symptoms and unequivocally and consistently low testosterone (Bhasin et al., 2018).
Corrected Evidence-Based Interpretation
Accurate.
Rationale for Grade
The article explicitly separates a prescribing trend from clinical need, which is the main interpretive error in other coverage of prescribing data. Its diagnostic statement matches the guideline. It does not make benefit claims beyond the evidence.
References
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID
Supporting excerpt: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs"